加拿大安大略省2009-2015年百日咳疫苗效果:频数匹配人群病例对照研究
加拿大免疫研究网络在安大略省开展频数匹配人群病例对照研究,纳入2009年1月1日至2015年3月31日法定报告的1335例百日咳病例和5340例随机人群对照。结果显示,2-3岁儿童疫苗效果为92%(95%CI 88-95%),8-9岁为90%(95%CI 80-95%),12-13岁降至49%(95%CI 2-73%);14-16岁青少年加强剂后疫苗效果为76%(95%CI 52-88%),16-22岁为78%(95%CI -31至96%)。免疫程序及时完成者,末次接种后第一年疫苗效果为87%(95%CI 84-90%),8年及以上降至74%(95%CI 63-82%)。
要点
- 2-3岁儿童百日咳疫苗效果为92%,8-9岁为90%。
- 12-13岁儿童疫苗效果降至49%(95%CI 2-73%)。
- 14-16岁青少年加强剂后疫苗效果为76%(95%CI 52-88%)。
核心结论
- 百日咳疫苗效果在生命第一个十年较高,之后迅速下降。
- 青少年加强剂不能完全恢复保护。
- 研究结果与高中儿童局部暴发一致,强调需额外政策保护婴儿。
研究设计与样本
- 频数匹配人群病例对照研究,纳入1335例法定报告百日咳病例和5340例随机人群对照。
- 病例符合安大略省确诊或疑似病例定义,对照按年龄、初级保健提供者和诊断年份频数匹配。
- 使用多变量逻辑回归估计粗比值比和调整比值比(aOR)。
主要发现
- 2-3岁儿童疫苗效果为92%(95%CI 88-95%),8-9岁为90%(95%CI 80-95%)。
- 12-13岁儿童疫苗效果降至49%(95%CI 2-73%)。
- 14-16岁青少年加强剂后疫苗效果为76%(95%CI 52-88%),16-22岁为78%(95%CI -31至96%)。
- 免疫程序及时完成者,末次接种后第一年疫苗效果为87%(95%CI 84-90%),8年及以上为74%(95%CI 63-82%)。
临床怎么用
- 监测百日咳疫苗效果随年龄下降,关注12-13岁儿童保护力减弱。
- 评估青少年加强剂效果,考虑额外策略保护婴儿。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Resurgences of pertussis have occurred in several high-income countries, often linked to waning of immunity from acellular pertussis vaccines. The degree of waning observed has varied by study design and setting. In Ontario, pertussis has not shown a substantial resurgence in the past decade. The routine immunization schedule comprises three priming doses in infancy, toddler and pre-school doses, and an adolescent dose at 14-16 years of age. METHODS: We estimated pertussis vaccine effectiveness (VE) through a case-control study of 1335 cases statutorily reported to public health in Ontario and occurring between January 1, 2009 and March 31, 2015, compared with 5340 randomly selected population controls, frequency-matched by age, primary-care provider and year of diagnosis. Pertussis cases met provincial confirmed or probable case definitions. We used multivariable logistic regression to estimate crude and adjusted odds ratios (aOR). RESULTS: VE against pertussis was sustained between 92% (95% confidence interval (95%CI) 88-95%) in 2-3 year olds and 90% (95%CI: 80-95%) in 8-9 year olds, but fell rapidly to 49% (95%CI: 2-73%) in children 12-13 years of age. VE following the teenage booster given at 14-16 years in Ontario reached 76% (95%CI: 52-88%) in 14-16 year olds and 78% (95%CI: -31 to 96%) in those 16-22 years old. For children who were up-to-date with the immunization schedule, VE declined from 87% (95%CI: 84-90%) during the first year to 74% (95%CI: 63-82%) after 8 or more years following their last dose of immunization. CONCLUSIONS: VE is high during the first decade of life but then falls rapidly. Protection is not fully restored by the teenage booster. Our findings are consistent with the localized outbreaks we observe in high school children and underline the importance of additional policies to protect infants.
引用
- Crowcroft NS, Schwartz KL, Chen C, et al. Pertussis vaccine effectiveness in a frequency matched population-based case-control Canadian Immunization Research Network study in Ontario, Canada 2009-2015. Vaccine. 2019. PMID: 30967309. doi:10.1016/j.vaccine.2019.02.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。